Discount program: 5% OFF for the second order, 7% OFF for the third order.
Shop with us securely! We offer re-shipment guarantees.
We always provide new, legal products of impeccable quality.
Please make sure that the product is legal in your country and not under any restrictions before ordering.
We do not sell pharmaceutical products or controlled substances.
Synthetic cannabinoid THJ-018, also known as SGT-17, has been offered online as a designer drug. This drug is a JWH-018 indazole analog noted for its potency as a synthetic cannabinoid. Due to its dangerous effects on human health, THJ-018 has been a source of worry for law enforcement authorities and health groups, despite its popularity among drug users.
The Rise of Synthetic Cannabinoids: A New Threat
Synthetic cannabinoids, often known as designer medicines, are chemically created substances that replicate the effects of natural cannabinoids like THC. The use of synthetic cannabinoids has increased in recent years, resulting in a rise in health and safety concerns. The widespread usage of THJ-018, one of the most potent synthetic cannabinoids on the market, has prompted considerable concerns about the hazards presented by these substances.
The Chemical Structure of THJ-018
THJ-018 is a synthetic cannabinoid that shares structural similarities with JWH-018, a famous synthetic cannabinoid that has been banned in many nations. The chemical is well-known for its capacity to bind to cannabinoid receptors in the brain, resulting in euphoric effects comparable to those of natural cannabinoids. Despite its strength, THJ-018 is not regulated, and its consumers must be aware of its molecular makeup.
The Dangers of THJ-018
The use of THJ-018 and other synthetic cannabinoids can result in various severe health consequences, including a fast heart rate, high blood pressure, disorientation, seizures, hallucinations, and even death. In addition, the long-term effects of these medications on the brain and body are unclear, and there is a considerable danger of addiction and dependency.
Frequently Asked Questions
What exactly is THJ-018?
THJ-018 is a synthetic cannabinoid offered online as a designer drug. It is the indazole analog of JWH-018.
How does THJ-018 work?
THJ-018 binds to cannabinoid receptors in the brain, producing a spectrum of psychotropic effects comparable to those of natural cannabinoids.
What are the risks posed by THJ-018?
The use of THJ-018 and other synthetic cannabinoids can result in various severe health consequences, including a fast heart rate, high blood pressure, disorientation, seizures, hallucinations, and even death. Unknown are the long-term consequences of these medications on the brain and body, and the likelihood of addiction and dependency is significant.
To prepare the content, the following materials were used:
Substance Registration System
Hazardous Substances Data Bank. National Library of Medicine. 28
August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
Liver transplant modulates gut microbial dysbiosis and cognitive
function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S
Siddiqui, Puneet Puri...
Differential impact of hyponatremia and hepatic encephalopathy on
health-related quality of life and brain metabolite abnormalities in cirrhosis .
By Jasmohan Bajaj
An overview of alcohol and other drug issues
Medicating the mind: a Kantian analysis of overprescribing
psychoactive drugs B A Manninen
pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli
and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
Inhibition of plasma membrane monoamine transporters by
β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin,
Peyton JacobIII, Arnold Eruoho
Schedules of Controlled Substances: Placement of Methylone Into
of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids,
mephedrone, and more)
Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug
Enforcement Administration McLean, Virginia
Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll
Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
Drug Use in Relation to Outcome of Mammography Screening. von
Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug
Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne,
Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and
Nicola Biagio Mercuri
evidence for a reciprocal interaction between amphetamine and cocaine-related
drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder:
Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller,
author Hannah L. Hays Alfred Aleguas.
effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and
estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
Drug Safety Communication: Safety Review Update of Medications used to treat
Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged
Controlled Substances Act
The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of
the influence of functional group modifications to the core scaffold of
synthetic cathinones on drug pharmacokinetics